Trial Profile
Diagnostic Multicenter Phase II Study, Prospective, Comparative, of 68Ga-HBED-PSMA PET / CT and Conventional Imaging Procedures in Occult Biological Relapse Prostate Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Acronyms PSMA REBIOLOC
- 20 May 2021 Status changed from active, no longer recruiting to completed.
- 14 May 2019 Status changed from recruiting to active, no longer recruiting.
- 29 May 2018 Planned End Date changed from 29 Sep 2018 to 29 Sep 2019.